The potential role of cannabinoids in dermatology
- 01The skin has its own endocannabinoid system regulating inflammation and cell growth
- 02Cannabinoids like CBD and THC show potential in reducing itch and inflammation
- 03These compounds may inhibit the excessive skin cell proliferation characteristic of psoriasis
- 04Research is in early stages and requires more controlled clinical trials
Cannabinoids may offer new pathways for treating inflammatory skin conditions by interacting with the skin's own receptor system.
Cannabis is increasingly being used world-wide to treat a variety of dermatological conditions. Medicinal cannabis is currently legalized in Canada, 31 states in America and 19 countries in Europe. The authors reviewed the literature on the pharmacology and use of cannabinoids in treating a variety of skin conditions including acne, atopic dermatitis, psoriasis, skin cancer, pruritus, and pain. Cannabinoids have demonstrated anti-inflammatory, antipruritic, anti-ageing, and antimalignancy properties by various mechanisms including interacting with the newly found endocannabinoid system of the skin thereby providing a promising alternative to traditional treatments.
- APA
- Tabrez Sheriff, Matthew J Lin, Danielle Dubin, & Hooman Khorasani (2020). The potential role of cannabinoids in dermatology. https://fasciaresearchdatabase.com/the-potential-role-of-cannabinoids-in-dermatology/
- MLA
- Tabrez Sheriff, et al. "The potential role of cannabinoids in dermatology." 2020, https://fasciaresearchdatabase.com/the-potential-role-of-cannabinoids-in-dermatology/.
- Chicago
- Tabrez Sheriff et al. 2020. "The potential role of cannabinoids in dermatology.". https://fasciaresearchdatabase.com/the-potential-role-of-cannabinoids-in-dermatology/